Author: arron37p2980
Starting its Industrial Investment in Biotech Companies, China Medical System (0867.HK) has Accelerated its Flywheel of Innovation
China Medical System Holdings Limited (0867.HK) (“CMS” or the “Company”) has been active in the market this year. From the acquisition of Luqa to enter the medical aesthetic market early this year, the Company has attracted the attention of the market. Recently, it announced a series of agreements signed with Trinomab Biotech Co., Ltd. (“Trinomab”). CMS will make an equity investment in Trinomab, and establish a joint venture (“JV”) with Trinomab, contributed with cash and related products technologies by CMS and Trinomab respectively. The Joint Venture will entrust CMS with the clinical development and commercialization of all its products in ... Read more